Patent ID: 11891401
Assignee: NOVARTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 2:
3. The co-crystal of claim 1, which is characterized by one of more selected from: (a) an X-ray powder diffraction pattern that is substantially as shown in FIG. 4 when measured with a CuKα radiation at a wavelength of 0.15 nm; (b) a differential scanning calorimetry (DSC) thermogram that is substantially as shown in FIG. 5 when heated from 30 to 300° C. at a rate of 10 K/min; and (c) a thermogravimetric analysis (TGA) diagram that is substantially as shown in FIG. 6 when heated from 30 to 300° C. at a rate of 10 K/min.